Skip to main content

Table 1 Patient characteristcs of the resectable (i) and recurrent (ii) cohort

From: FOXO transcriptional activity is associated with response to chemoradiation in EAC

 

Resectable cohort (i)

Recurrent cohort (ii)

n = 236

100%

n = 66

100%

Mean age at dianosis

57.6

(36–81)

64.7

(40–85)

Sex

 Male

200

84.7

51

77.3

 Female

36

15.3

15

22.7

Location

 Proximal

1

0.4

0

0.0

 Mid

1

0.4

3

4.5

 Distal

58

24.6

41

62.1

 GEJ

176

74.6

22

33.3

T-stage

 1

5

2.1

3

4.5

 2

35

14.8

5

7.6

 3

192

81.4

57

86.4

 4

4

1.7

1

1.5

N-stage

 0

75

31.8

16

24.2

 1

140

59.3

41

62.1

 2

1

0.4

7

10.6

 3

20

8.5

2

3.0

Treatment

 nCRT

172

72.9

15

22.7

 nCRT + P

27

11.4

2

3.0

 CRT + HT

0

0.0

1

1.5

 CT

0

0.0

1

1.5

 Surgery only

37

15.7

47

71.2

Mandard grade

 1

26

11.0

0

0.0

 2

38

16.1

1

1.5

 3

77

32.6

10

15.2

 4

40

16.9

6

9.1

 5

18

7.6

1

1.5

 NA

37

15.7

48

72.7

Recurrence

128

54.2

66

100.0

Alive

75

31.8

5

7.6

  1. Similar clinicalpathological distributions observed in both cohorts, P = panitumumab
  2. Mandard grade NA due to no nCRT, surgery only